Objectives The main objective of this study was to investigate the relationship among the in
vivo acquisition of antimicrobial resistance in Pseudomonas aeruginosa clinical isolates, the …

Recent reports have revealed the existence of widespread extensively drug-resistant (XDR)
P. aeruginosa high-risk clones in health care settings, but there is still scarce information on …

Pseudomonas aeruginosa, a Gram-negative bacterium, is a member of the ESKAPE
pathogens and one of the leading causes of healthcare-associated infections worldwide …

Pseudomonas aeruginosa, a leading nosocomial pathogen, may become multidrug
resistant (MDR). Its rate of occurrence, the individual risk factors among affected patients …

Limited therapy options due to antibiotic resistance underscore the need for optimization of
current diagnostics. In some bacterial species, antimicrobial resistance can be …

We describe the molecular characterization of a multiresistant Pseudomonas aeruginosa
clone causing an outbreak in the intensive care unit (ICU) of a tertiary-care university …

Pseudomonas aeruginosa is a ubiquitous, motile, gram-negative bacterium that has been
recently identified as a multi-drug resistant pathogen in critical need of novel therapeutics. Of …

Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative opportunistic pathogen that
infects patients with cystic fibrosis, burn wounds, immunodeficiency, chronic obstructive …

Antibiotic resistance is a worldwide health issue spreading quickly among human and
animal pathogens, as well as environmental bacteria. Misuse of antibiotics has an impact on …

Pseudomonas aeruginosa (P. aeruginosa) is one of the most common nosocomial
pathogens worldwide. Although the emergence of multidrug-resistant (MDR) P. aeruginosa …